Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Metastatic breast cancer (BCa) is most often diagnosed months after completion of treatment of the primary tumor when a patient reports physical symptoms. Besides a physical examination, no other alternative recurrence screening method is recommended for routine follow-up care.